Summary
The ability of peptidoglycan monomer (PGM), an immunomodulator obtained fromBrevibacterium divaricatum, to modulate NK and ADCC activities of spleen cells was tested in mice with constitutively weak (C57B1) or strong NK activity (CBA, C3H). In weak reactors, i.v. injection of PGM enhanced the NK and ADCC activity as effectively as a known stimulator, poly I.C, and the dynamics of the response was comparable. In strong reactors, PGM caused two peaks of the ADCC response, and one peak of NK stimulation (after an initial decline), whereas poly I.C caused more or less persistent stimulation of both activities. Incubation of spleen cells with PGM was generally less effective than the treatment in vivo. No alteration of NK activity was recorded at high effector-to-target ratio (E:T), and at low ones, PGM caused suppression. This was true both for weakly and strongly reactive cells. ADCC was either unchanged (CBA spleen cells), stimulated (C3H), or suppressed at high E:T and enhanced at low E:T (C57B1). PGM apparently activates an interlocked regulatory mechanism, and the final outcome probably depends on relative concentrations of regulatory and effector cells and on their per cell activities. Hence the effect varied with the time interval between treatment and assay, with strain-related constitutive reactivity, and with the E:T ratio.
Similar content being viewed by others
Abbreviations
- ADCC:
-
antibody-dependent cellular cytotoxicity
- IFN:
-
interferon
- IL-1:
-
Interleukin 1
- IL-2:
-
interleukin 2
- MDP:
-
muramyl dipeptide
- NK:
-
natural killer
- PFC:
-
plaque-forming cell
- PGM:
-
peptidoglycan monomer
- poly I.C:
-
polyinosinic-polycytidylic acid
References
Adam A, Petit J-F, Lefrancier P, Lederer E (1981) Muramyl peptides. Chemical structure, biological activity and mechanism of action. Molec Cell Biochem 41:27–47
Chedid L (1986) Neuroimmunopharmacological activities of muramyl peptides. In: Cinader B, Miller RG (eds) Progress in immunology, vol 6. Academic Press, Orlando, p915
Goguel A-F, Payelle B, Lespinats G, Nauciel C (1983) Cytotoxic responses induced by peptidoglycans with or without in vivo antitumor activity. JNCI 71:325–330
Goguel A-F, Lespinats G, Nauciel C (1982) Peptidoglycan extracted from gram-positive bacteria: Expression of antitumor activity according to peptide structure and route of injection. JNCI 68:657–663
Hanna N, Fidler IJ (1980) Role of natural killer cells in the destruction of circulating tumor emboli. JNCI 65:801–809
Herberman RB, Ortaldo JR (1981) Natural killer cells: their role in defence against diseases. Science 214:24–30
Hršak I, Tomašić J, Pavelić K, Benković B (1979) On the mechanism of immunostimulatory activity of monomeric peptidoglycans. Period Biol 81:155–157
Hršak I, Tomašić J, Pavelić K, Valinger Z (1979) Stimulation of humoral immunity by peptidoglycan monomer fromBrevibacterium divaricatum. Z Immun Forsch 155:312–318
Hršak I, Novak Đ, Tomašić J (1980) Immunostimulating activity of peptidoglycan monomer (PGM) on in vivo primary response to sheep erythrocytes,Salmonella typhimurium and Newcastle disease virus. Period Biol 82:147–151
Hršak I, Tomašić J, Osmak M (1983) Immunotherapy of B-16 melanoma with peptidoglycan monomer. Eur J Cancer Clin Oncol 19:681–686
Keglević D, Ladešić B, Tomašić J, Valinger Z, Naumski R (1979) Isolation procedure and properties of monomer unit from lysozyme digest of peptidoglycan complex exerted into the medium of penicillin-treatedBrevibacterium divaricatum mutant. Biochim Biophys Acta 585:273–281
Leclerc C, Juy D, Chedid L (1979) Inhibitory and stimulatory effects of synthetic glycopeptide (MDP) on the in vitro PFC response: factors affecting the response. Cell Immunol 42:336–343
Le Garrec Y, Morin A (1987) Modulation of natural killer activity by muramyl peptides: relationship with adjuvant anti-infectious properties. Natl Immunol Cell Growth Regul 6:65–76
Masihi KN, Lange W, Rohde-Schulz B (1987) Modulation of natural killer cytotoxicity by muramyl dipeptide and trehalose dimycolate incorporated in squalene droplets. Cancer Immunol Immunother 24:19–24
Merrill JE (1983) Natural Killer (NK) and antibody-dependent cellular cytotoxicity (ADCC) activities can be differentiated by their different sensitivities to interferon and prostaglandin E1. J Clin Immunol 3:42–50
Pavelić K, Bernacki RJ, Vuk-Pavlović S (1987) Insulin-modulated interleukin-2 production by murine splenocytes and T-cell hybridoma. J Endocrinol 114:89–94
Rakočević S (1986) Nonspecific active immunotherapy of a fibrosarcoma based on monitoring specific immune reaction and phagocytosis in tumor-bearing mice. Thesis, University of Zagreb, Faculty of Veterinary Medicine
Räsänen L, Arvilommi H (1982) Cell walls, peptidoglycans, and teichoic acid of grammpositive bacteria as polyclonal inducers and immunomodulators of proliferative and lymphokine responses of human B- and T-lymphocytes. Infect Immun 35:523–527
Sava G, Giraldi T, Tomašić J, Hršak I (1983) Immunotherapy of Lewis lung carcinoma with hydrosoluble peptidoglycan monomer (PGM). Cancer Immunol Immunother 15:84–86
Sava G, Tomašić J, Hršak I (1984) Antitumor and antimetastatic activity of the immunoadjuvant peptidoglycan monomer PGM in mice bearing MCa mammary carcinoma. Cancer Immunol Immunother 18:49–53
Sharma SD, Tsai V, Krahenbuhl JL, Remington JS (1981) Augmentation of mouse natural killer cell activity by muramyl dipeptide and its analogs. Cell Immunol 62:101–109
Talmadge JE, Schneider M, Collins M, Phillips H, Herberman RB, Wiltrout RH (1985) Augmentation of NK cell activity in tissue specific sites by lyposomes incorporating MTPPE. J Immunol 135:1477–1483
Taniyama T, Holden HT (1979) Direct augmentation of cytolitic activity of tumor-derived macrophages and macrophage cell lines by muramyl dipeptide. Cell Immunol 48:369–374
Vermeulen MW, David JR, Remold HG (1987) Differential mRNA responses in human macrophages activated by interferon-γ and muramyl dipeptide. J Immunol 139:7–9
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gabrilovac, J., Tomašić, J., Boranić, M. et al. In vivo and in vitro modulation of NK and ADCC activities of mouse spleen cells by peptidoglycan monomer (PGM). Res. Exp. Med. 189, 265–273 (1989). https://doi.org/10.1007/BF01852258
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01852258